Language selection

Search

Details for: INFLECTRA

Company: CELLTRION HEALTHCARE CO LTD

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02419475INFLECTRAINFLIXIMAB100 MG / VIALPOWDER FOR SOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary
Regulatory Decision Summary
Summary Safety Review - REMICADE (infliximab) - Evaluating for the Risk of Cancer (Lymphoma, Hepatosplenic T-Cell Lymphoma, and Leukemia)
Summary Safety Review - Tumour necrosis factor (TNF) blockers - Glioblastoma (brain tumour)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: